OIA
NBIX icon

OneDigital Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History

OneDigital Investment Advisors’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,800
Closed -$33K – 769
2021
Q1 		$33K Buy
+2,800
New +$294K ﹤0.01% 667

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

OneDigital Investment Advisors's NBIX Position: Q2 2026 in Review

OneDigital Investment Advisors reduced its Neurocrine Biosciences (NBIX) stake by 0.26% in Q2 2026, selling an estimated $1.33K and leaving 3,493 shares worth $589K. The position accounts for 0.01% of the portfolio, ranked #974.

OneDigital Investment Advisors first reported a position in NBIX in Q1 2021 and has held it in 11 quarters since. The position peaked at $691K in Q2 2024. 526 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • OneDigital Investment Advisors held 3,493 shares of Neurocrine Biosciences worth $589K as of Q2 2026.
  • OneDigital Investment Advisors sold 9 Neurocrine Biosciences shares in Q2 2026, an estimated $1.33K.
  • Neurocrine Biosciences made up 0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #974 holding.
  • OneDigital Investment Advisors first reported a position in Neurocrine Biosciences in Q1 2021 and has held it in 11 quarters since.
  • OneDigital Investment Advisors's Neurocrine Biosciences position peaked at $691K in Q2 2024.
  • 526 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.